These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17205)

  • 21. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients.
    Mayumi H; Himeno K; Tanaka K; Tokuda N; Fan JL; Nomoto K
    Transplantation; 1986 Oct; 42(4):417-22. PubMed ID: 3532453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of the regional graft vs. host reaction in F1 mice preliminarily treated intrahepatically with semiallogeneic lymphocytes].
    Divanian Kh
    Eksp Med Morfol; 1986; 25(4):43-7. PubMed ID: 3816649
    [No Abstract]   [Full Text] [Related]  

  • 24. Models for the production of stable hematopoietic chimerism across major histocompatibility barriers in adults.
    Wegmann TG; Rosovsky J; Carlson GA; Diener E; Drell DW
    J Immunol; 1980 Oct; 125(4):1751-7. PubMed ID: 7410851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 27. Decreased graft-versus-host reaction and T cell cytolytic potential of beige mice.
    Halle-Pannenko O; Bruley-Rosset M
    Transplantation; 1985 Jan; 39(1):85-7. PubMed ID: 3880970
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunofluorescence and elution studies in tetraparental NZB forms and is formed from CFW chimaeras and graft-versus-host diseased NZB.
    Barnes RD; Holliday J; Tuffrey M
    Immunology; 1974 Jun; 26(6):1195-206. PubMed ID: 4368790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental transplantation of allogeneic spleen tissue].
    Majewski W
    Ann Acad Med Stetin; 1988; 34():161-75. PubMed ID: 3256254
    [No Abstract]   [Full Text] [Related]  

  • 31. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K; Algara DS; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory action of liver extracts on the splenic index and mortality in the graft vs. host reaction].
    Divanian Kh; Dimitrov K
    Eksp Med Morfol; 1985; 24(4):11-7. PubMed ID: 3914410
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Brok HP; Vossen JM; Heidt PJ
    Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure to detect maternal modification of H-Y in mice.
    Silvers WK
    Transplantation; 1977 Feb; 23(2):196-7. PubMed ID: 319584
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of genetic differences between mother and fetuses in the development of the graft vs host reaction induced in the mother].
    Fedosov EA; Fedorov GN; Kostiukov AA
    Biull Eksp Biol Med; 1980 Mar; 89(3):340-2. PubMed ID: 7388144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study of H-2 mutations in mice. V. Detection of mutations M505, Hzl and M506 in the host vs transplant reaction].
    Mnatsakanian IuA; Egorov IK
    Genetika; 1975; 11(10):30-2. PubMed ID: 5338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
    Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.